Cyient DLM Soars as Earnings Double; Bandhan Bank Slides Despite Profit Hike

Cyient DLM Soars as Earnings Double; Bandhan Bank Slides Despite Profit Hike

Cyient DLM Soars as Earnings Double; Bandhan Bank Slides Despite Profit Hike​

Tech and Industry Stocks Show Resilience Amid Q2 Results​

Market sentiment remains focused on company-specific developments following a series of quarterly earnings announcements. Shares of Cyient DLM surged, gaining 11% after reporting a sharp improvement in financial performance. The consolidated net profit more than doubled to ₹16.3 crore, up from ₹7.5 crore a year ago. This growth was supported by revenue rising 34.3 percent Year-on-Year (YoY) to reach ₹373.8 crore.

TVS Holdings shares also jumped 5% after the company announced robust June quarter earnings. The consolidated net profit saw a significant increase of 73.8 percent YoY, reaching ₹1,173.6 crore. Furthermore, TVS Holdings’ revenue increased by 34 percent to stand at ₹17,076.2 crore.

Mixed Reactions in Banking and Hospitality Sectors​

Despite reporting profitable quarterly figures, shares of Bandhan Bank shed 10% during the trading session. The stock movement occurred even though the company reported a strong profit growth of 35 percent. The consolidated profit rose to ₹501.7 crore for the quarter ended June 2026, up from ₹372 crore in the previous year period.

Similarly, Indian Hotels traded lower despite posting healthy quarterly results. Consolidated net profit increased by 20.8 percent YoY, reaching ₹357.9 crore. Revenue for the company rose 14.6 percent to ₹2,339.2 crore, but investor reaction was muted.

Corporate Announcements and Regulatory Milestones​

Aurobindo Pharma shares dropped 2% after its subsidiary, CuraTeQ Biologics, received necessary regulatory approval. The subsidiary gained ANVISA approval from Brazil’s National Health Surveillance Agency for its biosimilars manufacturing facility in Hyderabad. This milestone followed a successful Good Manufacturing Practice (GMP) inspection conducted earlier in May.

In corporate news, Maruti Suzuki shares were sighted trading higher after the company announced significant price hikes across its model portfolio. The revised prices will be effective from August 2026 and include an increase of up to ₹30,000, citing a sustained rise in input costs.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top